{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,19]],"date-time":"2026-06-19T23:42:46Z","timestamp":1781912566045,"version":"3.54.5"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"1","funder":[{"name":"BMBF (InfectControl 2020)"},{"name":"BMBF (InfectControl 2020)"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Microb Cell Fact"],"published-print":{"date-parts":[[2017,12]]},"DOI":"10.1186\/s12934-017-0756-z","type":"journal-article","created":{"date-parts":[[2017,8,17]],"date-time":"2017-08-17T11:46:22Z","timestamp":1502970382000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Optimization of the biotechnological production of a novel class of anti-MRSA antibiotics from Chitinophaga sancti"],"prefix":"10.1186","volume":"16","author":[{"given":"Amelie","family":"Beckmann","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephan","family":"H\u00fcttel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Viktoria","family":"Schmitt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rolf","family":"M\u00fcller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7284-8671","authenticated-orcid":false,"given":"Marc","family":"Stadler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,8,17]]},"reference":[{"key":"756_CR1","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1016\/S0140-6736(06)68853-3","volume":"368","author":"H Grundmann","year":"2006","unstructured":"Grundmann H, Aires-de-Sousa M, Boyce J, Tiemersma E. Emergence and resurgence of meticillin-resistant Staphylococcus aureus as a public-health threat. Lancet. 2006;368:874\u201385.","journal-title":"Lancet"},{"key":"756_CR2","unstructured":"World Health Organization. Antimicrobial resistance: global report on surveillance. 2014. http:\/\/apps.who.int\/iris\/bitstream\/10665\/112642\/1\/9789241564748_eng.pdf . Accessed 2 May 2017."},{"key":"756_CR3","doi-asserted-by":"crossref","first-page":"1763","DOI":"10.1001\/jama.298.15.1763","volume":"298","author":"RM Klevens","year":"2007","unstructured":"Klevens RM, Morrison MA, Nadle J, Petit S, Gershman K, Ray S, et al. Invasive methicillin-resistant Staphylococcus aureus infections in the United States. JAMA. 2007;298:1763\u201371.","journal-title":"JAMA"},{"key":"756_CR4","doi-asserted-by":"crossref","first-page":"19688","DOI":"10.2807\/ese.15.41.19688-en","volume":"15","author":"R K\u00f6ck","year":"2010","unstructured":"K\u00f6ck R, Becker K, Cookson B, van Gemert-Pijnen J, Harbarth S, Kluytmans J, et al. Methicillin-resistant Staphylococcus aureus (MRSA): burden of disease and control challenges in Europe. Euro Surveil. 2010;15:19688.","journal-title":"Euro Surveil"},{"key":"756_CR5","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1186\/1745-6215-15-233","volume":"15","author":"S Kalimuddin","year":"2014","unstructured":"Kalimuddin S, Phillips R, Gandhi M, de Souza NN, Low JGH, Archuleta S, et al. Vancomycin versus daptomycin for the treatment of methicillin-resistant Staphylococcus aureus bacteremia due to isolates with high vancomycin minimum inhibitory concentrations: study protocol for a phase IIB randomized controlled trial. Trials. 2014;15:233.","journal-title":"Trials"},{"key":"756_CR6","doi-asserted-by":"crossref","first-page":"1670","DOI":"10.1016\/S0140-6736(97)07324-8","volume":"350","author":"K Hiramatsu","year":"1997","unstructured":"Hiramatsu K, Aritaka N, Hanaki H, Kawasaki S, Hosoda Y, Hori S, et al. Dissemination in Japanese hospitals of strains of Staphylococcus aureus heterogeneously resistant to vancomycin. Lancet. 1997;350:1670\u20133.","journal-title":"Lancet"},{"key":"756_CR7","doi-asserted-by":"crossref","first-page":"1342","DOI":"10.1056\/NEJMoa025025","volume":"348","author":"S Chang","year":"2003","unstructured":"Chang S, Sievert DM, Hageman JC, Boulton ML, Tenover FC, Downes FP, et al. Infection with vancomycin-resistant Staphylococcus aureus containing the vanA resistance gene. N Engl J Med. 2003;348:1342\u20137.","journal-title":"N Engl J Med"},{"key":"756_CR8","doi-asserted-by":"crossref","first-page":"5285","DOI":"10.1128\/JCM.43.10.5285-5287.2005","volume":"43","author":"MK Hayden","year":"2005","unstructured":"Hayden MK, Rezai K, Hayes RA, Lolans K, Quinn JP, Weinstein RA. Development of daptomycin resistance in vivo in methicillin-resistant Staphylococcus aureus. J Clin Microbiol. 2005;43:5285\u20137.","journal-title":"J Clin Microbiol"},{"key":"756_CR9","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1086\/428616","volume":"40","author":"A Mangili","year":"2005","unstructured":"Mangili A, Bica I, Snydman DR, Hamer DH. Daptomycin-resistant, methicillin-resistant Staphylococcus aureus bacteremia. Clin Infect Dis. 2005;40:1058\u201360.","journal-title":"Clin Infect Dis"},{"key":"756_CR10","unstructured":"World Health Organization. Global priority list of antibiotic-resistant bacteria to guide research, discovery, and development of new antibiotics. 2017. http:\/\/www.who.int\/medicines\/publications\/WHO-PPL-Short_Summary_25Feb-ET_NM_WHO.pdf?ua=1 . Accessed 2 May 2017."},{"key":"756_CR11","doi-asserted-by":"crossref","first-page":"14605","DOI":"10.1002\/anie.201409964","volume":"53","author":"S Baumann","year":"2014","unstructured":"Baumann S, Herrmann J, Raju R, Steinmetz H, Mohr KI, H\u00fcttel S, et al. Cystobactamids: myxobacterial topoisomerase inhibitors exhibiting potent antimicrobial activity. Angew Chem Int Ed. 2014;53:14605\u20139.","journal-title":"Angew Chem Int Ed"},{"key":"756_CR12","doi-asserted-by":"crossref","first-page":"3937","DOI":"10.1002\/anie.201411028","volume":"54","author":"U Le\u0161nik","year":"2015","unstructured":"Le\u0161nik U, Luke\u017ei\u010d T, Podgor\u0161ek A, Horvat J, Polak T, \u0160ala M, et al. Construction of a new class of tetracycline lead structures with potent antibacterial activity through biosynthetic engineering. Angew Chem Int Ed. 2015;54:3937\u201340.","journal-title":"Angew Chem Int Ed"},{"key":"756_CR13","doi-asserted-by":"crossref","first-page":"13588","DOI":"10.1002\/anie.201406973","volume":"53","author":"F Surup","year":"2014","unstructured":"Surup F, Viehrig K, Mohr KI, Herrmann J, Jansen R, M\u00fcller R. Disciformycins A and B: 12-membered macrolide glycoside antibiotics from the myxobacterium Pyxidicoccus fallax active against multiresistant staphylococci. Angew Chem Int Ed. 2014;53:13588\u201391.","journal-title":"Angew Chem Int Ed"},{"key":"756_CR14","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/jac\/29.suppl_A.1","volume":"29","author":"REW Hancock","year":"1992","unstructured":"Hancock REW, Bellido F. Factors involved in the enhanced efficacy against gram-negative bacteria of fourth generation cephalosporins. J Antimicrob Chemother. 1992;29:1\u20136.","journal-title":"J Antimicrob Chemother"},{"key":"756_CR15","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/S0196-4399(97)82485-3","volume":"19","author":"JC Fung-Tomc","year":"1997","unstructured":"Fung-Tomc JC. Fourth-generation cephalosporins. Clin Microbiol Newsl. 1997;19:129\u201336.","journal-title":"Clin Microbiol Newsl"},{"key":"756_CR16","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1007\/82_2016_496","volume-title":"How to overcome antibiotic crisis\u2014facts, challenges, technologies and future perspectives","author":"S Karwehl","year":"2016","unstructured":"Karwehl S, Stadler M. Exploitation of fungal biodiversity for discovery of novel antibiotics. In: Stadler M, Dersch P, editors. How to overcome antibiotic crisis\u2014facts, challenges, technologies and future perspectives. Cham: Springer International Publishing; 2016. p. 303\u201338."},{"key":"756_CR17","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1002\/anie.201005226","volume":"50","author":"H Steinmetz","year":"2011","unstructured":"Steinmetz H, Gerth K, Jansen R, Schl\u00e4ger N, Dehn R, Reinecke S, et al. Elansolid A, a unique macrolide antibiotic from Chitinophaga sancti isolated as two stable atropisomers. Angew Chem Int Ed. 2011;50:532\u20136.","journal-title":"Angew Chem Int Ed"},{"key":"756_CR18","doi-asserted-by":"crossref","first-page":"3882","DOI":"10.1002\/anie.201006880","volume":"50","author":"R Dehn","year":"2011","unstructured":"Dehn R, Katsuyama Y, Weber A, Gerth K, Jansen R, Steinmetz H, et al. Molecular basis of elansolid biosynthesis: evidence for an unprecedented quinone methide initiated intramolecular Diels-Alder cycloaddition\/macrolactonization. Angew Chem Int Ed. 2011;50:3882\u20137.","journal-title":"Angew Chem Int Ed"},{"key":"756_CR19","doi-asserted-by":"crossref","first-page":"11254","DOI":"10.1002\/anie.201500927","volume":"54","author":"KI Mohr","year":"2015","unstructured":"Mohr KI, Volz C, Jansen R, Wray V, Hoffmann J, Bernecker S, et al. Pinensins: the first antifungal lantibiotics. Angew Chem Int Ed. 2015;54:11254\u20138.","journal-title":"Angew Chem Int Ed"},{"key":"756_CR20","doi-asserted-by":"crossref","first-page":"7739","DOI":"10.1002\/chem.201100457","volume":"17","author":"R Jansen","year":"2011","unstructured":"Jansen R, Gerth K, Steinmetz H, Reinecke S, Kessler W, Kirschning A, et al. Elansolid A3, a unique p-quinone methide antibiotic from Chitinophaga sancti. Chem Eur J. 2011;17:7739\u201344.","journal-title":"Chem Eur J"},{"key":"756_CR21","doi-asserted-by":"crossref","first-page":"1813","DOI":"10.1002\/cbic.201200228","volume":"13","author":"H Steinmetz","year":"2012","unstructured":"Steinmetz H, Zander W, Shushni MA, Jansen R, Gerth K, Dehn R, et al. Precursor-directed syntheses and biological evaluation of new elansolid derivatives. ChemBioChem. 2012;13:1813\u20137.","journal-title":"ChemBioChem"},{"key":"756_CR22","doi-asserted-by":"crossref","first-page":"5291","DOI":"10.1002\/chem.201605884","volume":"23","author":"LL Wang","year":"2017","unstructured":"Wang LL, Candito D, Dr\u00e4ger G, Herrmann J, M\u00fcller R, Kirschning A. Harnessing a p-quinone methide intermediate in the biomimetic total synthesis of the highly active antibiotic 20-deoxy-elansolid B1. Chem Eur J. 2017;23:5291\u20138.","journal-title":"Chem Eur J"},{"key":"756_CR23","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1038\/nrmicro1994","volume":"6","author":"J-M Pag\u00e8s","year":"2008","unstructured":"Pag\u00e8s J-M, James CE, Winterhalter M. The porin and the permeating antibiotic: a selective diffusion barrier in gram-negative bacteria. Nat Rev Microbiol. 2008;6:893\u2013903.","journal-title":"Nat Rev Microbiol"},{"key":"756_CR24","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1007\/BF00171945","volume":"42","author":"AP Zeng","year":"1995","unstructured":"Zeng AP. Effect of CO2 absorption on the measurement of CO2 evolution rate in aerobic and anaerobic continuous cultures. Appl Microbiol Biotechnol. 1995;42:688\u201391.","journal-title":"Appl Microbiol Biotechnol"},{"key":"756_CR25","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1002\/bit.260360513","volume":"36","author":"S Aiba","year":"1990","unstructured":"Aiba S, Furuse H. Some comments on respiratory quotient (RQ) determination from the analysis of exit gas from a fermentor. Biotechnol Bioeng. 1990;36:534\u20138.","journal-title":"Biotechnol Bioeng"},{"key":"756_CR26","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1002\/bit.260401002","volume":"40","author":"PN Royce","year":"1992","unstructured":"Royce PN. Effect of changes in the pH and carbon dioxide evolution rate on the measured respiratory quotient of fermentations. Biotechnol Bioeng. 1992;40:1129\u201338.","journal-title":"Biotechnol Bioeng"},{"key":"756_CR27","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1021\/ol403441c","volume":"16","author":"A Weber","year":"2014","unstructured":"Weber A, Dehn R, Schl\u00e4ger N, Dieter B, Kirschning A. Total synthesis of the antibiotic elansolid B1. Org Lett. 2014;16:568\u201371.","journal-title":"Org Lett"},{"key":"756_CR28","doi-asserted-by":"crossref","first-page":"2223","DOI":"10.1099\/ijs.0.64359-0","volume":"56","author":"P K\u00e4mpfer","year":"2006","unstructured":"K\u00e4mpfer P, Young CC, Sridhar KR, Arun AB, Lai WA, Shen FT, et al. Transfer of [Flexibacter] sancti, [Flexibacter] filiformis, [Flexibacter] japonensis and [Cytophaga] arvensicola to the genus Chitinophaga and description of Chitinophaga skermanii sp. nov. Int J Syst Evol Microbiol. 2006;56:2223\u20138.","journal-title":"Int J Syst Evol Microbiol"},{"key":"756_CR29","doi-asserted-by":"crossref","first-page":"87","DOI":"10.4056\/sigs.661199","volume":"2","author":"T Glavina Del Rio","year":"2010","unstructured":"Glavina Del Rio T, Abt B, Spring S, Lapidus A, Nolan M, Tice H, et al. Complete genome sequence of Chitinophaga pinensis type strain (UQM 2034). Stand Genom Sci. 2010;2:87\u201395.","journal-title":"Stand Genom Sci"},{"key":"756_CR30","doi-asserted-by":"crossref","first-page":"D490","DOI":"10.1093\/nar\/gkt1178","volume":"42","author":"V Lombard","year":"2014","unstructured":"Lombard V, Golaconda Ramulu H, Drula E, Coutinho PM, Henrissat B. The carbohydrate-active enzymes database (CAZy) in 2013. Nucleic Acids Res. 2014;42:D490\u20135.","journal-title":"Nucleic Acids Res"},{"key":"756_CR31","doi-asserted-by":"crossref","first-page":"e0139932","DOI":"10.1371\/journal.pone.0139932","volume":"10","author":"LS McKee","year":"2015","unstructured":"McKee LS, Brumer H. Growth of Chitinophaga pinensis on plant cell wall glycans and characterisation of a glycoside hydrolase family 27 \u03b2-L-arabinopyranosidase implicated in arabinogalactan utilisation. PLoS ONE. 2015;10:e0139932.","journal-title":"PLoS ONE"},{"key":"756_CR32","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.mib.2008.02.007","volume":"11","author":"J Deutscher","year":"2008","unstructured":"Deutscher J. The mechanisms of carbon catabolite repression in bacteria. Curr Opin Microbiol. 2008;11:87\u201393.","journal-title":"Curr Opin Microbiol"},{"key":"756_CR33","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1038\/nrmicro1932","volume":"6","author":"B G\u00f6rke","year":"2008","unstructured":"G\u00f6rke B, St\u00fclke J. Carbon catabolite repression in bacteria: many ways to make the most out of nutrients. Nat Rev Microbiol. 2008;6:613\u201324.","journal-title":"Nat Rev Microbiol"},{"key":"756_CR34","doi-asserted-by":"crossref","first-page":"6647","DOI":"10.1093\/nar\/9.24.6647","volume":"9","author":"C Yanofsky","year":"1981","unstructured":"Yanofsky C, Platt T, Crawford IP, Nichols BP, Christie GE, Horowitz H, et al. The complete nucleotide sequence of the tryptophan operon of Escherichia coli. Nucleic Acids Res. 1981;9:6647\u201368.","journal-title":"Nucleic Acids Res"},{"key":"756_CR35","doi-asserted-by":"crossref","first-page":"297","DOI":"10.4155\/fmc.11.191","volume":"4","author":"C Ji","year":"2012","unstructured":"Ji C, Ju\u00e1rez-Hern\u00e1ndez RE, Miller MJ. Exploiting bacterial iron acquisition: siderophore conjugates. Future Med Chem. 2012;4:297\u2013313.","journal-title":"Future Med Chem"},{"key":"756_CR36","doi-asserted-by":"crossref","first-page":"8272","DOI":"10.1002\/anie.201701358","volume":"56","author":"K Ferreira","year":"2017","unstructured":"Ferreira K, Hu HY, Fetz V, Prochnow H, Rais B, M\u00fcller PP, et al. Multivalent siderophore-DOTAM conjugates as theranostics for imaging and treatment of bacterial infections. Angew Chem Int Ed. 2017;56:8272\u20136.","journal-title":"Angew Chem Int Ed"}],"container-title":["Microbial Cell Factories"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12934-017-0756-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,10,15]],"date-time":"2020-10-15T14:35:52Z","timestamp":1602772552000},"score":1,"resource":{"primary":{"URL":"http:\/\/microbialcellfactories.biomedcentral.com\/articles\/10.1186\/s12934-017-0756-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,8,17]]},"references-count":36,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017,12]]}},"alternative-id":["756"],"URL":"https:\/\/doi.org\/10.1186\/s12934-017-0756-z","relation":{},"ISSN":["1475-2859"],"issn-type":[{"value":"1475-2859","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,8,17]]},"article-number":"143"}}